China's drug market is booming, and will soon be the fifth largest in the world. But despite this potential, global companies are being advised to approach the country with caution, as Colin Macilwain reports.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Handle with care. Nature 440, 990–991 (2006). https://doi.org/10.1038/440990a
Published:
Issue Date:
DOI: https://doi.org/10.1038/440990a
This article is cited by
-
Time Trends and Determinants of Pharmaceutical Expenditure in China (1990–2009)
PharmacoEconomics (2014)
-
In brief
Nature (2007)
-
In brief
Nature (2006)
-
In brief
Nature (2006)